In our study, ENO2 was highly expressed in the tissues of ccRCC patients and played a role in activating the cell cycle, EMT, and PI3K/AKT signaling pathway, which was consistent with our expectations. Here, ENO2 is linked to nonpapillary renal cell carcinoma.